Protective effects of docosahexaenoic acid supplementation on cognitive dysfunction and hippocampal synaptic plasticity impairment induced by early postnatal PM2.5 exposure in young rats.
Level 5 - mechanism / opinion, no new human data
Non-clinical animal research
PubMed 38459987 · doi:10.1007/s00210-024-03028-4
What was done
Neonatal rats were randomized into three experimental groups: control, PM2.5 exposure, and DHA plus PM2.5 exposure. The authors evaluated the effect of DHA supplementation on PM2.5-induced cognitive and neurodevelopmental alterations by assessing learning and memory performance, hippocampal synaptic plasticity (long-term potentiation, synaptic ultrastructure, and synaptic protein expression), CREB/BDNF signaling, neuroinflammatory markers (IBA-1, IL-1β, IL-6), and oxidative stress markers (SOD1, Nrf2).
What was found
The abstract reports directional outcomes without exact numerical values or statistics. DHA co-treatment ameliorated PM2.5-induced deficits in learning and memory, enhanced long-term potentiation, restored synaptic ultrastructure, and elevated synaptic protein expression. DHA also increased CREB phosphorylation, BDNF, SOD1, and Nrf2 levels, while reducing levels of IBA-1, IL-1β, and IL-6 relative to the PM2.5-only group.
Why it matters
The findings identify DHA as a potential protective candidate against early-life PM2.5-induced neurotoxicity by modulating synaptic plasticity, neuroinflammation, and oxidative stress pathways in a rodent model.
Limits
The study is restricted to neonatal rats, limiting direct translation to human infants. The abstract omits sample size, exposure concentrations, DHA dosing details, exposure durations, and all quantitative effect sizes and confidence intervals.
Cited by
- supports DHA acts as a COX-2 inhibitor and directly enhances BDNF (brain-derived neurotrophic factor) production.